NLRP3 and tuberculosis: Therefore, we hypothesized that low-dose TB treatment increased the abundance of SCFAs-producing bacteria, thereby increasing SCFAs contents, inhibiting LPS-induced NLRP3 inflammasome activation, and alleviating the inflammatory response.